AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21182491
Drug: Buprenorphine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (20 µg·h(‐1), 144 h)
Trial: 21182491
Drug: Fentanyl (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (25 µg·h(‐1), 72 h)
Trial: 17165496
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine Paishi Decoction, 40 mL of 33% magnesium sulfate, 30 mL of 0.5% hydrochloric acid, fat diet, and Tuian Yunjing Instrument
Trial: 10765962
Drug: DMPS (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMPS (2 mg/kg body weight) injected intravenously
Trial: 9050975
Drug: Sustained-release verapamil/trandolapril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release verapamil/trandolapril
Trial: 9050975
Drug: Lisinopril/hydrochlorothiazide
RxNorm normalized name: lisinopril/hydrochlorothiazide 20 mg-25 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril/hydrochlorothiazide
Trial: 8288503
Drug: Ceftazidime 2
RxNorm normalized name: ceftazidime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 2 g tds
Trial: 3506198
Drug: Solutions made
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solutions made in experimental villages
Trial: 3506198
Drug: Solutions made
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solutions made in control villages
Trial: 27315583
Drug: Fulvestrant (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulvestrant (500 mg)
Trial: 9586668
Drug: Clodronate (1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate (1600 mg/day orally)
Trial: 2686433
Drug: Intravenous diphenylhydantoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diphenylhydantoin (1,000 mg)
Trial: 4926948
Drug: Control (Blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Blood Urea Concentration < 40 mg/100 ml)
Trial: 4926948
Drug: Control (Blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Blood Urea Concentration 40-79 mg/100 ml)
Trial: 4926948
Drug: Control (Blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Blood Urea Concentration ≥ 80 mg/100 ml)
Trial: 7352850
Drug: Methadone hydrochloride
RxNorm normalized name: Methadone Hydrochloride
DrugBank: Methadone (DB00333)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methadone hydrochloride (60 mg daily)
Trial: 7352850
Drug: Methadone hydrochloride
RxNorm normalized name: Methadone Hydrochloride
DrugBank: Methadone (DB00333)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methadone hydrochloride (increased doses)
Trial: 30194663
Drug: Low-dose daily
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose daily prednisolone (0.2-0.3 mg/kg daily)
Trial: 30194663
Drug: Standard alternate-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard alternate-day prednisolone (0.5-0.7 mg/kg alternate day)
Trial: 21777100
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n=5, intact teeth without preparation or restoration)
Trial: 17322141
Drug: Telmisartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (80 mg) with nisoldipine (10 mg)
Trial: 8279942
Drug: 0.01 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg/kg per hour of recombinant human IGF-I
Trial: 3183852
Drug: Heparin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin and dipyridamole
Trial: 27122214
Drug: 200 U
RxNorm normalized name: lipase 1200 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 U Botulinum‐A toxin injection
Trial: 27122214
Drug: 300 U
RxNorm normalized name: lactase 3300 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 U Botulin‐A toxin injection
Trial: 27122214
Drug: 200 U
RxNorm normalized name: lipase 1200 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 U Botulin‐A toxin injection
Trial: 27122214
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses of Botulinum‐A toxin
Trial: 21485709
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (Xobix)
Trial: 21485709
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (Melfax)
Trial: 9492717
Drug: Extraamniotic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extraamniotic saline infusion
Trial: 9492717
Drug: Intracervical application
RxNorm normalized name: eladocagene exuparvovec
DrugBank: Eladocagene exuparvovec (DB16780)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical application of dinoprost 0.5 mg (prostaglandin)
Trial: 8045656
Drug: Allopurinol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (600 mg before operation)
Trial: 2692571
Drug: Maxepa (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxepa (20 capsules/day)
Trial: 4908341
Drug: Amantadine hydrochloride
RxNorm normalized name: Amantadine Hydrochloride
DrugBank: Amantadine (DB00915)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amantadine hydrochloride (100 mg, twice daily for 10 days)
Trial: 23685830
Drug: Fibrin spray
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin spray (10 mL)
Trial: 21864624
Drug: Matrix M™
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matrix M™ adjuvanted virosomal H5N1 vaccine (1.5, 7.5, or 30 μg HA with 50 μg Matrix M™)
Trial: 21864624
Drug: Virosomal H5N1
RxNorm normalized name: influenza, H5N1-1203
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virosomal H5N1 vaccine alone (30 μg HA)
Trial: 11331165
Drug: 10 micro
RxNorm normalized name: Estradiol 10 microgram vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micro g/kg neostigmine
Trial: 11331165
Drug: 5 micro
RxNorm normalized name: Filter Connector 5 micron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 micro g/kg neostigmine
Trial: 9060525
Drug: Concurrent chemoradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiation at weeks 1 to 4 (Group I)
Trial: 8359923
Drug: CVD 103-HgR
RxNorm normalized name: Vibrio cholerae CVD 103-hgr strain live antigen
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 103-HgR live oral cholera vaccine (5 x 10^9 CFU)
Trial: 8359923
Drug: CVD 103-HgR
RxNorm normalized name: Vibrio cholerae CVD 103-hgr strain live antigen
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 103-HgR live oral cholera vaccine (5 x 10^8 CFU)
Trial: 3772096
Drug: Regular alcohol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular alcohol consumption (0.8 g/kg per day)
Trial: 31854112
Drug: One-month dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-month dual anti-platelet therapy (DAPT) with ticagrelor and aspirin followed by 23-month ticagrelor monotherapy
Trial: 31854112
Drug: Experimental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental treatment (ticagrelor monotherapy after DAPT)
Trial: 31854112
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (standard DAPT followed by aspirin)
Trial: 23106929
Drug: Concomitant psychotropic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant psychotropic medication use
Trial: 16095144
Drug: Fluticasone propionate-salmeterol
RxNorm normalized name: Fluticasone Propionate/Salmeterol Xinafoate 55 MCG/1 ACTUATION-14 MCG/1 ACTUATION Inhalation Powder [FLUTICASONE PROPIONATE-SALMETEROL XINAFOATE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate-salmeterol (100/50 microg) twice daily for 12 weeks
Trial: 16095144
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (100 microg) alone twice daily for 12 weeks
Trial: 10490110
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) and UV-A combination treatment
Trial: 10490110
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of FP and UV-A
Trial: 26951772
Drug: Non-I-BiT games
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-I-BiT games (non-interactive binocular treatment)
Trial: 20737524
Drug: Ondansetron (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (4 mg) plus fluoxetine (20 mg/day)
Trial: 12639367
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 mg/day) plus placebo
Trial: 18799202
Drug: Tamsulosin, 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin, 0.4 mg/d
Trial: 10649929
Drug: Gluma Desensitizer
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gluma Desensitizer (rescue treatment)
Trial: 23072081
Drug: Acupuncture and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture and Tuina therapy (group A)
Trial: 15291377
Drug: Olmesartan (2.5-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (2.5-80 mg once daily)
Trial: 2006597
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (morphine, meperidine, ketobemidone)
Trial: 6754485
Drug: khellin, orally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: khellin, orally administered for 4 months with subsequent exposure to natural sunlight
Trial: 12150168
Drug: Heptavalent pneumococcal
RxNorm normalized name: botulinum neurotoxin B immune FAB2
DrugBank: Equine Botulinum Neurotoxin B Immune FAB2 (DB13903)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heptavalent pneumococcal conjugate vaccine
Trial: 2503865
Drug: Parenteral glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral glucose by intravenous infusion
Trial: 30900550
Drug: Multicomponent intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multicomponent intervention including a webinar, monthly reports of general practice-specific data for antibiotic prescribing, and decision support tools.
Trial: 21392622
Drug: Idebenone (450/900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idebenone (450/900 mg/d or 1,350/2,250 mg/d)
Trial: 17854242
Drug: Risperidone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (2 mg with dinner)
Trial: 17854242
Drug: Quetiapine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (100 mg with dinner and 100 mg with breakfast)
Trial: 15497673
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg sultamicillin tablets (Duobaktam 750 mg tablets)
Trial: 15497673
Drug: 250 mg/5mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/5mL sultamicillin suspension (Duobaktam 250 mg/5mL)
Trial: 9399753
Drug: Methotrexate (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (12.5 mg weekly)
Trial: 3665340
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not receiving anticonvulsant therapy)
Trial: 3665340
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of prednisone and methylprednisolone
Trial: 3665340
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of anticonvulsant therapy
Trial: 3665340
Drug: Combination anticonvulsant
RxNorm normalized name: ANTICONVULSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination anticonvulsant therapy
Trial: 24622830
Drug: Beer (4.7%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beer (4.7% vol, 400 ml)
Trial: 24622830
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (13.7% vol, 200 ml)
Trial: 24622830
Drug: Whisky (43.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whisky (43.5% vol, 100 ml)
Trial: 24622830
Drug: Isotonic glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic glucose solution
Trial: 24622830
Drug: Ethanol solutions
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol solutions of identical proof
Trial: 24622830
Drug: Control ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control ethanol solutions
Trial: 16311751
Drug: Biopsychosocial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biopsychosocial therapy (BT; n=31)
Trial: 16311751
Drug: Conventional biomedical
RxNorm normalized name: hypromellose
DrugBank: Hypromellose (DB11075)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional biomedical therapy (MT; n=33)
Trial: 12747192
Drug: De Nol
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: De Nol triple therapy
Trial: 8607332
Drug: Anticoagulant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant therapy (oral anticoagulants replaced with heparin from 6 to 12 weeks, vitamin K antagonists during second and third trimesters, heparin after 36 weeks until 10 days postpartum)
Trial: 8607332
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not specified, but implied to be those not receiving anticoagulant therapy)
Trial: 3894257
Drug: tiaprofenic acid
RxNorm normalized name: tiaprofenic acid
DrugBank: Tiaprofenic acid (DB01600)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tiaprofenic acid 600 mg daily
Trial: 3894257
Drug: indomethacin 75
RxNorm normalized name: indomethacin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: indomethacin 75 mg daily
Trial: 26409247
Drug: Free pregnancy
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free pregnancy test kits provided to CHWs (treatment group)
Trial: 24628950
Drug: Hyperthermic intraperitoneal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperthermic intraperitoneal chemotherapy with oxaliplatin
Trial: 24628950
Drug: Perioperative systemic
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perioperative systemic chemotherapy and D1-D2 curative gastrectomy
Trial: 15608044
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (group L, n=21) received i.v. saline
Trial: 15608044
Drug: Perineural tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perineural tramadol group (group T, n=20) received i.v. saline and PCB with tramadol 1.5 mg kg(‐1)
Trial: 15608044
Drug: Systemic tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic tramadol group (group IT, n=19) received i.v. tramadol 1.5 mg kg(‐1)
Trial: 8530798
Drug: Tapering course
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tapering course of prednisone (historical control)
Trial: 23117723
Drug: Extended-duration enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-duration enoxaparin prophylaxis (40 mg daily for 28±4 days)
Trial: 17034954
Drug: Oral progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral progesterone (400mg)
Trial: 14523053
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg q.d.
Trial: 14523053
Drug: Fenofibrate 200
RxNorm normalized name: fenofibrate 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 200 mg q.d.
Trial: 11271244
Drug: Acyclovir (3200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (3200 mg/day if creatinine clearance > 50 ml/min, intravenously for first 90 days)
Trial: 3051990
Drug: Diltiazem (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (60 to 180 mg twice daily)
Trial: 3051990
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 to 75 mg twice daily)
Trial: 3051990
Drug: Diltiazem and
RxNorm normalized name: Diltiazem and enalapril only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem and Captopril in combination
Trial: 17348223
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity ultrasound treatment
Trial: 9309988
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate 100 micrograms twice daily
Trial: 9309988
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate 500 micrograms twice daily
Trial: 9309988
Drug: Oral fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fluticasone propionate 20 mg once daily
Trial: 8318328
Drug: Induction of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction of anaesthesia with propofol 3‐5 mg kg‐1 followed by maintenance with halothane and an appropriate regional block
Trial: 8318328
Drug: Induction and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction and maintenance of anaesthesia with a computerized, target‐controlled infusion of propofol with a regional block
Trial: 2882769
Drug: neostigmine 0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: neostigmine 0.07 mg kg‐1
Trial: 2882769
Drug: edrophonium 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: edrophonium 0.8 mg kg‐1
Trial: 27870712
Drug: Irosustat 40
RxNorm normalized name: Irosustat
DrugBank: Irosustat (DB02292)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irosustat 40 mg/d
Trial: 16784014
Drug: Pharmacologic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacologic treatment (control group)
Trial: 12915642
Drug: Glyburide/Metformin tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide/Metformin tablets (1.25/250 mg)
Trial: 12915642
Drug: Glyburide (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide (2.5 mg)
Trial: 12915642
Drug: Glyburide/Metformin tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide/Metformin tablets
Trial: 8750803
Drug: 1 alpha‐hydroxyvitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 alpha‐hydroxyvitamin D3 (1 alpha‐OHD3) at a dose of 0.05 microgram/kg per day for 1 year
Trial: 31152038
Drug: Colchicine 0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine 0.01 mg/day
Trial: 31152038
Drug: Colchicine 0.005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine 0.005 mg/day
Trial: 26996228
Drug: Increased intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased intake of fruits and vegetables (≥500 g daily)
Trial: 24706088
Drug: Flecainide (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide (150 or 100 mg/day according to body weight)
Trial: 24706088
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no antiarrhythmic drugs)
Trial: 9069612
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus MLT (20 mg/day p.o. in the evening)
Trial: 3082163
Drug: Omnipaque 350
RxNorm normalized name: Omnipaque 350
DrugBank: Iohexol (DB01362)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omnipaque 350 mg l/ml (iohexol)
Trial: 3082163
Drug: Hexabrix 320
DrugBank: Ioxaglic acid (DB09313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hexabrix 320 mg l/ml (ioxaglate)
Trial: 24070115
Drug: Low-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose interferon suppository (1,000 IU) administered daily for 24 weeks
Trial: 15947913
Drug: Levobupivacaine 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 5 mg/ml
Trial: 15947913
Drug: Levobupivacaine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 2.5 mg/ml
Trial: 15947913
Drug: Lidocaine 10
RxNorm normalized name: lidocaine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 10 mg/ml with adrenaline
Trial: 10655439
Drug: FAC followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: FAC followed by high-dose chemotherapy (cyclophosphamide, etoposide, and cisplatin with autologous hematopoietic stem cell support)
Trial: 9289427
Drug: Hormonal treatment
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal treatment and spasmolytic drugs for patients with threatened abortion